Research ArticlePharmacognosy CommunicationsVol. 2 | Issue 3 | pp. 50–57Open access
Antimicrobial activity of Callistemon citrinus and Callistemon salignus methanolic extracts
- 1,2*
- 1 Biomolecular and Physical Sciences, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland 4111, AUSTRALIA.
- 2 Environmental Futures Centre, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland 4111, AUSTRALIA.
Published in Pharmacognosy Communications
Correspondence: I.E. Cock
Biomolecular and Physical Sciences, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland 4111, AUSTRALIA.; Environmental Futures Centre, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland 4111, AUSTRALIA.
Email: I.Cock@griffith.edu.au
- DOI:
- 10.5530/pc.2012.3.11
How to cite
Cock, I. Antimicrobial activity of Callistemon citrinus and Callistemon salignus methanolic extracts. Pharmacognosy Communications, 2(3), 50–57. https://doi.org/10.5530/pc.2012.3.11
Abstract
Introduction: Australian Callistemon species had a role as traditional bush medicine for Australian Aborigines, including use as an antiseptic agent. Despite this ethnobotanical usage, the antimicrobial properties of Callistemon spp. have not been rigorously studied. Methods: The antimicrobial activity of methanolic extracts of Callistemon citrinus and Callistemon salignus were investigated by disc diffusion and growth time course assays against a panel of bacteria and fungi. Toxicity was determined using the Artemia franciscana nauplii bioassay. Results: C. citrinus leaf extracts inhibited the growth of 43% and flower extracts inhibited the growth of 64% of the bacteria tested, respectively. Gram-positive bacteria (100% inhibited) were more susceptible to C. citrinus extracts than were Gram-negative bacteria (27% inhibited by leaf extracts; 55% inhibited by flower extracts). In comparison, C. salignus leaf extract inhibited the growth of 29% of the bacteria tested compared with 43% inhibited for the flower extract. Gram-positive bacteria (100% inhibited) were more susceptible to C. salignus leaf extract than were Gram-negative bacteria (9% inhibited). Similar results (27% Gram-negative bacteria inhibited and 100% Gram-positive bacterial inhibition) were also seen for C. salignus flower extract. Very little antifungal activity was seen for any extract with only C. albicans being inhibited by C. salignus leaf extract. The antibacterial activity of the C. citrinus and C. salignus flower extracts was further investigated by growth time course assays. These extracts showed significant growth inhibition activity in cultures of Bacillus cereus, Aeromonas hydrophilia, Pseudomonas fluorescens and Bacillus subtilis within 1 hour. All extracts displayed low toxicity in the Artemia franciscana nauplii bioassay. Conclusions: The low toxicity of these Callistemon extracts and their inhibitory bioactivity against a panel of bacteria validates Australian Aboriginal usage of Callistemon citrinus and Callistemon salignus as antiseptic agents and confirms their medicinal potential.
Keywords
Subject
Article metadata
| Title | Antimicrobial activity of Callistemon citrinus and Callistemon salignus methanolic extracts |
|---|---|
| Authors | I.E. Cock |
| Affiliations | Biomolecular and Physical Sciences, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland 4111, AUSTRALIA.; Environmental Futures Centre, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland 4111, AUSTRALIA. |
| Corresponding author | I.Cock@griffith.edu.au |
| Journal | Pharmacognosy Communications |
| Volume / Issue | Vol. 2, Issue 3 |
Also in this issue
- The Preventative Effect of Saffron Against Liver Cancerpp. 73–74
- Editorialpp. 1
- Effect of Basella rubra L. leaf extract on haematological parameters and amylase activitypp. 10–13
- Pharmacokinetic and Pharmacodynamic Interaction of Curcumin with Glimepiride in Normal and Diabetic Ratspp. 14–21
- Prevention of Liver Injury by Moringa oleifera aqueous leaf extract in rats treated with isoniazid and rifampicinpp. 22–25